Arctic Bioscience AS (OSL: ABS)
Norway
· Delayed Price · Currency is NOK 2.000
-0.080 (-3.85%)
Nov 22, 2024, 4:25 PM CET
Arctic Bioscience AS Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2017 |
| Operating Revenue | 31.42 | 33.75 | 34.27 | 21.52 | 20.5 | 30.04 | Upgrade
|
| Other Revenue | 0.46 | 0.01 | 0.2 | 0 | 0.1 | - | Upgrade
|
| Revenue | 31.88 | 33.76 | 34.47 | 21.52 | 20.59 | 30.04 | Upgrade
|
| Revenue Growth (YoY) | -18.57% | -2.07% | 60.21% | 4.48% | -31.45% | 20.89% | Upgrade
|
| Cost of Revenue | 22.24 | 23.98 | 22.63 | 15.72 | 15.18 | 17.81 | Upgrade
|
| Gross Profit | 9.64 | 9.78 | 11.84 | 5.8 | 5.41 | 12.23 | Upgrade
|
| Selling, General & Admin | 25.45 | 23.51 | 21.69 | 17.26 | 10.76 | 5.57 | Upgrade
|
| Other Operating Expenses | 28.97 | 29.47 | 21.15 | 25.96 | 15.13 | 8.67 | Upgrade
|
| Operating Expenses | 59.82 | 58.37 | 46.57 | 45.74 | 27.09 | 15.32 | Upgrade
|
| Operating Income | -50.19 | -48.59 | -34.73 | -39.94 | -21.67 | -3.08 | Upgrade
|
| Interest Expense | -1.83 | -0.99 | -0 | -0.34 | -0.51 | -0.47 | Upgrade
|
| Interest & Investment Income | 3.32 | 3.74 | 1.89 | 0.12 | 0.02 | 0.05 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.33 | 0.33 | 1.47 | -1.78 | -0.42 | -0.49 | Upgrade
|
| EBT Excluding Unusual Items | -48.37 | -45.51 | -31.36 | -41.94 | -22.59 | -3.99 | Upgrade
|
| Other Unusual Items | - | - | -2.66 | -0.64 | - | - | Upgrade
|
| Pretax Income | -48.37 | -45.51 | -34.02 | -42.58 | -22.59 | -3.99 | Upgrade
|
| Net Income | -48.37 | -45.51 | -34.02 | -42.58 | -22.59 | -3.99 | Upgrade
|
| Net Income to Common | -48.37 | -45.51 | -34.02 | -42.58 | -22.59 | -3.99 | Upgrade
|
| Shares Outstanding (Basic) | 25 | 25 | 24 | 24 | 14 | - | Upgrade
|
| Shares Outstanding (Diluted) | 25 | 25 | 24 | 24 | 14 | - | Upgrade
|
| Shares Change (YoY) | 1.32% | 3.88% | 0.60% | 75.31% | - | - | Upgrade
|
| EPS (Basic) | -1.91 | -1.79 | -1.39 | -1.75 | -1.63 | - | Upgrade
|
| EPS (Diluted) | -1.91 | -1.79 | -1.39 | -1.75 | -1.63 | - | Upgrade
|
| Free Cash Flow | -60.05 | -85.62 | -83.96 | -76 | -35.32 | - | Upgrade
|
| Free Cash Flow Per Share | -2.37 | -3.37 | -3.43 | -3.12 | -2.55 | - | Upgrade
|
| Gross Margin | 30.23% | 28.97% | 34.36% | 26.95% | 26.28% | 40.73% | Upgrade
|
| Operating Margin | -157.42% | -143.93% | -100.75% | -185.63% | -105.25% | -10.26% | Upgrade
|
| Profit Margin | -151.72% | -134.84% | -98.71% | -197.90% | -109.70% | -13.28% | Upgrade
|
| Free Cash Flow Margin | -188.35% | -253.65% | -243.58% | -353.22% | -171.52% | - | Upgrade
|
| EBITDA | -48.5 | -45.79 | -31 | -37.42 | -20.48 | -2 | Upgrade
|
| EBITDA Margin | -152.13% | -135.66% | -89.92% | -173.92% | -99.46% | -6.67% | Upgrade
|
| D&A For EBITDA | 1.69 | 2.79 | 3.73 | 2.52 | 1.19 | 1.08 | Upgrade
|
| EBIT | -50.19 | -48.59 | -34.73 | -39.94 | -21.67 | -3.08 | Upgrade
|
| EBIT Margin | -157.42% | -143.93% | -100.75% | -185.63% | -105.25% | -10.26% | Upgrade
|
| Revenue as Reported | 31.88 | 33.76 | 34.47 | 21.52 | 20.59 | 30.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.